Table 1.
Baseline characteristics of the participants (N=37) (adapted from Matejko et al [7] which is published under Creative Commons Attribution 4.0 International License [29]).
| Category | MDIa+SMBGb group (n=17, 46%) | AHCLc group (n=20, 54%) | P value |
| Gender (female), n (%) | 8 (47) | 8 (40) | .920 |
| Age (years), mean (SD) | 40.9 (7.8) | 39.8 (8.3) | .671 |
| Diabetes duration (years), mean (SD) | 17.6 (12.2) | 17.1 (12.2) | .749 |
| HbA1cd level at enrollment (%), mean (SD) | 7.4 (1.2) | 7.05 (0.8) | .349 |
| BMI (kg/m2), mean (SD) | 25.6 (2.64) | 24.5 (3.3) | .280 |
| Body weight (kg), mean (SD) | 77.7 (14.4) | 76.3 (14.7) | .774 |
aMDI: multiple daily injection.
bSMBG: self-monitoring of blood glucose.
cAHCL: Advanced Hybrid Closed Loop.
dHbA1c: hemoglobin A1c.